CD8A and neoplasm: A recent case report of a 51-year-old male with a recurrent GBM, who underwent LITT therapy and a subsequent tumor biopsy, revealed that LITT caused a significant increase in activated CD8 T cells, activated macrophages, and PD-L1 expression [31].